webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

M3-Nitrodienamine

  CAS No.:   Cat No.: BADC-00292   Purity: 95% (NMR). 4.5  

M3-Nitrodienamine is an effective ADC cytotoxin payload inducing DNA damage to trigger apoptosis in malignant cells. It plays a critical role in ADC design by enhancing selective delivery and tumor cell killing, useful for both solid and hematologic cancer therapies.

M3-Nitrodienamine

Structure of

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Cytotoxin
Molecular Formula
C17H22N2O2
Molecular Weight
286.37
Shipping
Room temperature, or blue ice upon request.
Shipping
Stable in dry state, store at + 4 °C, in dark place.

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Solubility
Well in alcohol, chloroform, acetonitrile and DMSO
Melting Point
159-160 °C.
Appearance
Solid powder.
Shipping
Room temperature, or blue ice upon request.
Storage
Stable in dry state, store at + 4 °C, in dark place.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Payload Development Biological Payload Chemical Payload Protein Toxin Nanocarrier Microtubule Inhibitors DNA Damaging Agents RNA Polymerase Inhibitors Protein Degraders

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Maytansine and Its Analogues Cytotoxic Agents Used in Antibody–Drug Conjugates Exatecan Mesylate in ADCs: A New Topo I Inhibitor What is Calicheamicin? What is Monomethyl Auristatin E (MMAE)? What is Monomethyl Auristatin F (MMAF)? What is Pyrrolobenzodiazepine (PBD)? Antiviral Potential of Thapsigargin in COVID-19 Research ADC Payloads Explained: Current Types and Cutting-Edge Research Progress Tubulin Inhibitors - Highly Potential ADC Payloads

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: LK-66 M | 3-alpha-iodo-Imperialine | M4-Nitrodienamine | Dihydroatisine HCl | 3-beta-iodo-Imperialine | M2-Nitrodienamine | Farletuzumab ecteribulin | Imperatoxin-Inhibitor | Donaxine iodomethylate | Muscarinic toxin 2 | M3-Nitrodienamine
Send Inquiry
Verification code
Inquiry Basket